This toolbox contains the ‘tools’ that can be explored and applied by countries who want to improve access to essential medicines by increasing transparency in the medicines supply chain through the creation of a multi-stakeholder alliance.  They range from guidance on household surveys that identify how medicines are used by patients to the types of medicines in short supply in a specific region. 

Experience has shown that the development of MeTA needs to be highly sensitive and responsive to the existing structures, procedures and individuals of a country. The guidance offered is indicative only – the tools have often been applied at different stages and in different ways in each of the countries.

The tools have been categorised into core tools that are viewed as fundamental to success and those which are helpful but not essential. The tools have also been categorised by the ‘phase’ they might best be applied in.

For each tool there is an outline of its objective and its output and some additional information on the resources and skills required for its implementation. There are also examples of where the tool has been successfully used.

Core Tools

These tools are fundamental to MeTA’s success. They will help create a successful multi-stakeholder alliance, establish a picture of the pharmaceutical market, and highlight weaknesses in the medicines supply chain.  

Multi-Stakeholder Alliance

The creation of a working alliance between the public, private and civil society sectors is a fundamental step in the development of MeTA.

The Information Gap

This phase establishes what data exists about the policies and practices that relate to the accessibility of essential medicines and the impact they are having. It identifies the gaps which need to be filled.  

Generating Evidence

New and reliable data is collected which presents a clear picture of the policies and practices that affect the accessibility of essential medicines. It starts to give an indication of the changes needed.

Sharing Information

Data is disclosed, validated and analysed so that it can inform new and effective policies and create greater accountability. This is done in a way that does not disadvantage or marginalise any one party.

From Evidence to Policy

The information collated in the previous phases helps set priorities and informs work plans, which are agreed by the alliance. They contain clear, specific and measurable goals and strategies for achieving them.

Blue tablets